文献速递胃肠外科

腹腔镜保脾No.10淋巴结清扫用于局部进展期胃上部癌的前瞻性多中心研究

Safety and feasibility of laparoscopic spleen-preserving No. 10 lymph node dissection for locally advanced upper third gastric cancer: a prospective, multicenter clinical trial.
PubMed 文献 · Surg Endosc · 2019-12-10

该前瞻性多中心研究纳入251例局部进展期胃上部癌患者,评估腹腔镜保脾全胃切除术中No.10淋巴结清扫的安全性与可行性。结果显示No.10淋巴结转移率为7.4%,术后并发症率13.6%,严重并发症率3.3%,死亡率0.4%,无中转开腹或脾切除。

要点

  • 局部进展期胃上部癌行腹腔镜保脾No.10淋巴结清扫安全可行。
  • No.10淋巴结转移率7.4%,pN3状态是独立危险因素。
  • 术后并发症率13.6%,严重并发症率3.3%,死亡率0.4%。

核心结论

  • 由经验丰富外科医生实施时,腹腔镜保脾全胃切除术治疗局部进展期胃上部癌安全有效,可用于需脾门淋巴结清扫的患者。

研究设计与样本

  • 前瞻性多中心临床研究,2016年9月至2017年10月共19家机构纳入251例cT2-4a、N-/+、M0的局部进展期胃上部癌患者,242例纳入符合方案分析。

主要发现

  • No.10淋巴结平均清扫数目为2.4枚,平均转移数目为0.1枚。
  • 18例(7.4%)存在No.10淋巴结转移,进展期胃癌患者中No.10淋巴结转移率为8.1%(18/223)。
  • pN3状态是No.10淋巴结转移的独立危险因素。
  • 术中并发症发生7例,无中转开腹或脾切除。
  • 术后总体并发症率为13.6%(33/242),严重并发症率为3.3%(8/242),死亡率为0.4%(1/242)。

临床怎么用

  • 对于需行脾门淋巴结清扫的局部进展期胃上部癌患者,可考虑由经验丰富的外科医生实施腹腔镜保脾全胃切除术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous retrospective studies have shown that laparoscopic spleen-preserving D2 total gastrectomy (LSTG) for advanced upper third gastric cancer (AUTGC) is safe. However, all previous studies were underpowered. We therefore conducted a prospective, multicenter study to evaluate the technical safety and feasibility of LSTG for patients with AUTGC. METHODS: Patients diagnosed with AUTGC (cT2-4a, N-/+, M0) underwent LSTG at 19 institutions between September 2016 and October 2017 were included. The number of No. 10 lymph node (LN) dissections, metastasis rates, intraoperative and postoperative complications were investigated. RESULTS: A total of 251 patients were enrolled in the study, and 242 patients were eligible for the per protocol analysis. The average numbers of No. 10 LN dissections and metastases were 2.4 and 0.1, respectively. Eighteen patients (7.4%) had No. 10 LN metastases, and among patients with advanced gastric cancer, the rate of No. 10 LN metastasis was 8.1% (18/223). pN3 status was an independent risk factor for No. 10 LN metastasis. Intraoperative complications occurred in 7 patients, but no patients required conversion to open surgery or splenectomy. The overall postoperative complication rate was 13.6% (33/242). The major complication and mortality rates were 3.3% (8/242) and 0.4% (1/242), respectively. The number of retrieved No. 10 LNs, No. 10 LN metastasis and TNM stage had no significant influence on postoperative complication rates. CONCLUSION: LSTG for AUTGC was safe and effective when performed by very experienced surgeons, this technique could be used in patients who needed splenic hilar lymph node dissection.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Zheng CH, Xu YC, Zhao G, et al. Safety and feasibility of laparoscopic spleen-preserving No. 10 lymph node dissection for locally advanced upper third gastric cancer: a prospective, multicenter clinical trial. Surg Endosc. 2019. PMID: 31823047. doi:10.1007/s00464-019-07306-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。